TABLE 2.
Laboratory (reference) | Detection methoda
|
||||||||
---|---|---|---|---|---|---|---|---|---|
Simplified PAP on BHIA-V4 | Simplified PAP on MHA | Broth microdilution (MIC) | Agar dilution (MIC) | Etest | PAP | Disk-agar | MicroScan | Resistant mutant emergence | |
Hiramatsu et al. (19) | I | CΨ | |||||||
Franchi et al. (11) | I | C* | |||||||
Ariza et al. (1) | X | X | |||||||
Kantzanou et al. (23) | I♣ | CΨ | C | C | |||||
Geisel et al. (14) | I | CΨ | |||||||
Wong et al. (39) | I | CΨ | CΨ | I | |||||
Bierbaum et al. (2) | I | CΨ | C | ||||||
Schmitz et al. (31) | X | X | X | X | |||||
Marchese et al. (26) | Iδ♣ | CΨ | C | ||||||
Kim et al. (24) | I | CΨ | C | ||||||
Bobin-Dubreux et al. (3) | Iφ | C | C | C | |||||
Reverdy et al. (30) | Iφ | C | C | C | I | ||||
Trakulsomboon et al. (37) | Iδ | C | C | C | |||||
Wootton et al. (41) | X | X | X | X |
Disk-agar, aztreonam disk on vancomycin salt; MicroScan, Microscan conventional gram-positive panels; I, initial screening test; C, confirmatory test; X, for the tests performed, did not distinguish between initial and confirmatory tests; *, PAP performed on MHA; Ψ, MIC determined on subclone recovered from initial screen; δ, 100 μl of starting cell suspension (instead of 10 μl) plated; φ, MHA with 2 μg of vancomycin per ml; ♣, McFarland standard of 1.0 (instead of 0.5) used.